Smoking Cessation
📧 Sign up to get email alerts when something new happens for Smoking Cessation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Meclizine as a Potential Smoking Cessation Treatment [Phase 2]
Phase 2 study evaluating meclizine as a potential treatment for smoking cessation has completed and posted results in 2014.
-
FDA approval · 2014-04-17FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approves a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2014-04-17FDA Approved: NICORETTE 4MG FRUIT CHILL GUM, LIL DRUG STORE — Supplemental Application (Lil' Drug Store Products, Inc.)
FDA approved a supplemental application for NICORETTE 4MG FRUIT CHILL GUM from Lil' Drug Store Products, Inc., adding this product to its ap…
-
FDA approval · 2014-03-27FDA Approved: DG HEALTH NICOTINE — Supplemental Application (Dolgencorp Inc)
The FDA approved a supplemental application for DG HEALTH NICOTINE (nicotine polacrilex) from Dolgencorp Inc, expanding the availability of …
-
FDA approval · 2014-03-25FDA Approved: QUITINE NICOTINE — Supplemental Application (QUITINE LLC)
The FDA approved a supplemental application for QUITINE NICOTINE (nicotine polacrylex) from QUITINE LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-02-21FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) filed by Haleon US Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Nicotine Mouth Film for Craving Relief. [Phase 3]
Phase 3 clinical trial evaluating a nicotine mouth film for craving relief in smokers has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)
Pfizer completed a post-marketing drug-use investigation for varenicline (Chantix/Champix) under regulatory commitments; results were posted…
-
FDA approval · 2013-10-29FDA Approved: QUITINE NICOTINE — Supplemental Application (QUITINE LLC)
FDA approves a supplemental application for QUITINE NICOTINE (nicotine polacrilex) by QUITINE LLC, expanding its approved use/formulation.
-
FDA approval · 2013-10-28FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2013-10-28FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Nicorette (nicotine polacrylex) from Haleon US Holdings LLC, marking an updated labeling und…
-
FDA approval · 2013-10-11FDA Approved: NICORETTE ORIGINAL — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE ORIGINAL (nicotine polacrilex) from Haleon US Holdings LLC.
-
FDA approval · 2013-08-07FDA Approved: NICORETTE — Supplemental Application (Haleon US Holdings LLC)
FDA approved a supplemental application for NICORETTE (nicotine polacrilex) from Haleon US Holdings LLC, authorizing changes to the product’…
-
FDA approval · 2013-05-16FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Dr. Reddys Laboratories Inc.)
FDA approved a supplemental application for the Nicotine Transdermal System from Dr. Reddy's Laboratories Inc.
-
CLINICAL_TRIALS trial_result · 2013-04-26Clinical Trial Update: Efficacy of Naltrexone in Women's Smoking Cessation [Phase 2]
Phase 2 clinical trial update evaluating the efficacy of naltrexone for smoking cessation in women; completed with results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Tailoring Varenicline to Individual Needs (TVIN Study) [Phase 3]
This update notes the completion of a Phase 3 trial evaluating tailoring varenicline therapy to individual needs for tobacco use disorder an…
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Distribution of Bupropion and Varenicline to Increase Smoking Cessation Attempts [Phase 4]
Phase 4 trial update on distributing bupropion and varenicline to increase smoking cessation attempts; completed with posted results.
-
FDA approval · 2013-02-22FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Original Flavor (nicotine polacrilex gum) from Rugby Laboratories…
-
FDA approval · 2013-01-28FDA Approved: NICOTINE POLACRILEX MINT — Supplemental Application (Walgreens)
FDA approved Walgreens' supplemental application for NICOTINE POLACRILEX MINT, a nicotine replacement therapy product containing nicotine po…
-
FDA approval · 2013-01-28FDA Approved: RUGBY NICOTINE POLACRILEX GUM, COATED MINT FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application from Rugby Laboratories to add a coated mint flavor to Rugby Nicotine Polacrilex Gum, a nicotine rep…
-
FDA approval · 2013-01-28FDA Approved: RUGBY NICOTINE POLACRILEX GUM, ORIGINAL FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application for Rugby Nicotine Polacrilex Gum, Original Flavor, a nicotine replacement therapy intended to aid s…
-
FDA approval · 2013-01-28FDA Approved: NICOTINE — Supplemental Application (P & L Development, LLC)
The FDA approved a supplemental application for nicotine polacrilex (nicotine) by P & L Development, LLC under ANDA079038, supporting its us…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: DPBRN Hygienists Internet Quality Improvement in Tobacco Cessation (HiQuit) [EARLY_Phase 1]
Completion status update for an early-phase 1 trial evaluating internet-based quality improvement for tobacco cessation led by the Dental Pr…
-
FDA approval · 2012-12-11FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Chantix (varenicline tartrate) from Pfizer. The action updates the product labeling.
-
CLINICAL_TRIALS trial_result · 2012-12-04Clinical Trial Update: Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving [Phase 2]
Phase 2 trial assessing a nicotine lozenge for relief of provoked acute craving in smoking and smoking cessation.